Congenital Heart Defects Clinical Trial
Official title:
Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery
Verified date | November 2017 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Malformations of the heart (congenital heart disease) are the most common congenital birth defects, occurring in about 1% of children. Each year, between 150-200 children will undergo open heart surgery at British Columbia Children's Hospital (BCCH) to repair the defect(s) in their heart. The abnormal structure of the heart or the open heart surgery may cause damage to the electrical system of the heart which can disturb the rhythm of the heart (arrhythmias), prolong recovery or be life-threatening. For this reason, temporary pacing wires are placed in the heart following surgery to ensure the heart rhythm is as normal as possible during the post-operative period (pacing). In recent years, scientists have recognized that pacing the heart from one area is not necessarily the same as pacing it from a different area. In fact, in some individuals with arrhythmias and poor heart function, pacing the heart from different areas can improve the pumping of the heart, resulting in better heart function. This form of treatment is called Cardiac Resynchronization Therapy (CRT) because it endeavours to optimize the pumping of the heart by changing the electrical activation of the heart. CRT has been used to a very limited extent in children. A few pediatric cardiologists have used CRT to help children who are in heart failure. We would like to determine whether pacing the heart from different areas after open heart surgery improves the child's heart function and aids his or her recovery.
Status | Completed |
Enrollment | 34 |
Est. completion date | November 2009 |
Est. primary completion date | November 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility |
Inclusion Criteria: Subjects will be eligible for enrollment in this study if they are undergoing cardiopulmonary bypass surgery for right or left ventricular surgery or biventricular surgery and (1) have intra-cardiac conduction delay or bundle branch block post-surgery; (2) have echocardiographic evidence of ventricular dyssynchrony; (3) have pre-existing conduction disease or bundle branch block; or (4) have pre-existing ventricular dyssynchrony. Exclusion Criteria: Subjects will be excluded if they: (1) have single ventricle morphology; (2) require post-operative ECMO; (3) have sustained atrial or ventricular arrhythmias that may complicate ventricular pacing; (4) are not able to have functioning epicardial pacemaker leads; (5) are, in the opinion of the intensivist, cardiologist or surgeon, not stable enough medically to participate in the study; or (6) are unwilling to provide informed consent or assent. |
Country | Name | City | State |
---|---|---|---|
Canada | Children's Heart Centre, British Columbia's Children's Hospital | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac Index | Baseline and after 20 minutes of pacing | ||
Secondary | Systolic Blood Pressure | |||
Secondary | Incidence of Low Output Syndrome | |||
Secondary | TDI Indices (Tissue Velocities, Tissue Tracking, Regional Strain, and Regional Strain Rates) | |||
Secondary | Inotropic Support | |||
Secondary | Ventilatory Support | |||
Secondary | QRS Duration | Baseline and after 20 minutes of pacing | ||
Secondary | Cardio-pulmonary Bypass Time | Baseline and after 20 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01671566 -
Interval Training in Adults With Congenital Heart Disease a Randomized Trial
|
N/A | |
Recruiting |
NCT01421030 -
Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques
|
Phase 0 | |
Withdrawn |
NCT00981591 -
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
|
Phase 1/Phase 2 | |
Completed |
NCT01567579 -
An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
|
||
Terminated |
NCT00208676 -
Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01941576 -
Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot
|
N/A | |
Completed |
NCT01475357 -
Intestinal Function in Neonates With Complex Congenital Heart Disease
|
N/A | |
Active, not recruiting |
NCT01227096 -
Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT01201486 -
Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester
|
N/A | |
Completed |
NCT02232399 -
Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?
|
Phase 2 | |
Completed |
NCT05191654 -
Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
|
||
Recruiting |
NCT06267859 -
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
|
Early Phase 1 | |
Completed |
NCT02320669 -
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
|
Phase 3 | |
Completed |
NCT01489475 -
Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass
|
N/A | |
Withdrawn |
NCT00579358 -
Molecular Basis of Congenital Heart Defects
|
||
Recruiting |
NCT01196182 -
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
|
||
Recruiting |
NCT04382573 -
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
|
||
Recruiting |
NCT03822442 -
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
|
||
Completed |
NCT00450684 -
Cardiac Resynchronization Therapy in Congenital Heart Defects
|
Phase 2/Phase 3 | |
Terminated |
NCT00208754 -
Heart Failure in Adult Patients With a History of Congenital Heart Disease
|
N/A |